3rd June 2019
On Thursday, May 9. 2019, in HubHub, Prague, an evening was dedicated to the final pitches of the international acceleration programme for digital start-ups with impactful innovation. Mikołaj Gurdała as a representative of EIT Health InnoStars was one of the Jury Members.
After careful evaluation of each presenting start-up, first position was awarded to InoCure, which answered the real healthcare need. Did you know that the development of a new drug takes approximately thirteen years? InoCure has developed a biomimicking 3D cell culture membrane with fibrous morphology, and this can significantly shorten the time needed for new drug development. It supports animal-free life science research, and saves a considerable amount in finance.
The jury panel for the #DEMODAY pitch competition was composed of international professionals covering all evaluated criteria – Mikolaj Gurdala from EIT Health; Evgeny Frolov, Business Development Director of ITACA Business Incubator; Jaroslav Novák from ePace Consultancy Agency; and Jan Kubalík, CEO of the DEX Innovation Centre, EIT Health RIS Hub.
More about DEXIC Accelerator programme
DEXIC Accelerator is a six-week programme that takes place in the city of Liberec in the Czech Republic. This year, 140 digital startups applied.
After a two-round selection process, seven groups were selected, their promising startups focusing on the acceleration of their core competencies in four areas – Product, Business Model, Negotiations with Investors, and above all, Marketing and Sales.
“#DEMODAY was the final public event of DEXIC Accelerator,” says the Head Mentor, Jan Kubalík. “The programme is aimed at supporting digital startups, which we strongly believe, have innovative ideas with a high potential of bringing new and enriching products into society. Often they are in the need of capital or lacking some additional skills.”
Four exciting companies receive expert mentoring
EIT Health helps promising firms commercialise
Supported start-up launches AI platform with Roche
Helping cancer patients with AI
EIT Health supported start-up Unhindr awarded £500,000
Unhindr has won funding to scale AI prosthetic device